Amany Belal
Amany Belal publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Synthesis and biological activity, Synthesis and Biological Evaluation and Cancer therapeutics and mechanisms.
- World rank
- #425,030 of 7,710,434 ranked researchers
- Rank in Saudi Arabia
- #1,725 of 25,688
- Works
- 142
- Citations
- 3.4k
- Citations per work
- 23.9
What does Amany Belal research?
Amany Belal's work is mostly in Chemistry (31%), Biochemistry, Genetics and Molecular Biology (14%), Medicine (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5841.0%
- Physical Sciences5437.8%
- Chemistry4330.6%
- Computer Science64.0%
- Materials Science53.2%
- Life Sciences2014.1%
- Health Sciences107.1%
- Medicine107.1%
- 1Organic Chemistry31% of their works
- 2Molecular Biology14% of their works
- 3Oncology5% of their works
- 4Computational Theory and Mathematics4% of their works
- 5Materials Chemistry3% of their works
- 6Pulmonary and Respiratory Medicine2% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Cancer therapeutics and mechanisms
- Computational Drug Discovery Methods
- Synthesis and Characterization of Heterocyclic Compounds
- Metal complexes synthesis and properties
- Quinazolinone synthesis and applications
- Inorganic and Organometallic Chemistry
Which keywords describe Amany Belal's research?
The keywords of their largest research topics: Medicinal Chemistry, Anticancer Agents, Heterocyclic Compounds, Biological Evaluation, Synthesis, Tubulin Inhibitors, Vascular Targeting Agents and Molecular Docking.
- Catalysis
- Indirubin
- Platinum-Based Drugs
- Cisplatin Resistance
- Drug Target Identification
- DNA
- Metal Complexes
- Antimicrobial
- Molecular Docking
- Tubulin Inhibitors
- Biological Evaluation
- Anticancer Agents
- Medicinal Chemistry
- Heterocyclic Compounds
- Synthesis
- Vascular Targeting Agents
- Anticancer
- Antimicrobial Activity
- Quinoxaline
- Topoisomerases
- Virtual Screening
- Drug Discovery
- Triazines
- Quinazoline
- Organic Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Medicinal Chemistry713 topics
- Anticancer Agents663 topics
- Heterocyclic Compounds643 topics
- Biological Evaluation413 topics
- Synthesis413 topics
- Tubulin Inhibitors351 topic
- Vascular Targeting Agents351 topic
- Molecular Docking272 topics
- Anticancer212 topics
- Antimicrobial212 topics
- Antimicrobial Activity201 topic
- Metal Complexes202 topics
- Quinoxaline201 topic
- DNA171 topic
- Topoisomerases171 topic
- Drug Target Identification161 topic
- Virtual Screening161 topic
- Cisplatin Resistance111 topic
- Drug Discovery111 topic
- Platinum-Based Drugs111 topic
- Triazines111 topic
- Indirubin101 topic
- Quinazoline101 topic
- Catalysis91 topic
- Organic Synthesis91 topic
Where does Amany Belal work?
Amany Belal's main affiliation in the publication record is Taif University, Saudi Arabia.
How many publications and citations does Amany Belal have?
OpenAlex counts 142 works and 3,389 citations for Amany Belal, an h-index of 35, ranking #425,030 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Amany Belal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.